Determinants of poor glycaemic control in type 2 diabetes in Dire Dawa City, Eastern Ethiopia: a case-control study
Alemayehu Molla Tekalign1, Hanna Lambero2, Aboma Motuma3
1Department of Internal Medicine, School of Medicine, Dire Dawa University, Dire Dawa, Ethiopia.
Background:
In Ethiopia, there is little evidence on the factors contributing to poor glycaemic control. This study aimed to identify determinants of poor glycaemic control among type 2 diabetes in Dire Dawa City, Eastern Ethiopia.
Methods:
A facility-based unmatched case-control study was conducted among type 2 diabetes mellitus patients in follow-up clinics. Cases were people with glycated haemoglobin (HbA1c) ≥7%, while those with HbA1c <7% were controls. A total of 190 patients were recruited in chronic follow-up diabetic clinics. The data were collected using structured questionnaire interviews and extracted from medical charts and entered into EpiData (EpiData Association, Odense, Denmark) and exported to Stata version 16.1 (StataCorp, College Station, TX, USA) for analysis. A binary logistic regression model was fitted to identify the determinants of poor glycaemic control.
Results:
The study showed that being female (adjusted odds ratio [AOR] 2.73 [95% confidence interval {CI} 1.10 to 6.79]), a smoker (AOR 14.85 [95% CI 5.25 to 42.88]), blood glucose monitoring ≤3 times per week (AOR 4.87 [95% CI 1.42 to 16.71]), overweight (AOR 4.96 [95% CI 1.82 to 13.52]) or obese (AOR 5.19 [95% CI 1.76 to 15.56]), ≥10 y on treatment (AOR 3.56 [95% CI 1.17 to 10.82]), having coronary artery disease (AOR 2.47 [95% CI 1.01 to 6.03]) and poor adherence to diabetic medication (AOR 0.24 [95% CI 0.10 to 0.63]) were found to be predictors of poor glycaemic control.
Conclusions:
Smoking, overweight or obese, poor medication adherence and blood glucose levels lead to poor glycaemic control. This study shows the benefits of quitting smoking, maintaining a healthy weight, adhering to medication and monitoring blood glucose levels.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...


